DK3081215T3 - Sammensætninger og fremgangsmåder til langvarig frigørelse af beta-alanin - Google Patents
Sammensætninger og fremgangsmåder til langvarig frigørelse af beta-alanin Download PDFInfo
- Publication number
- DK3081215T3 DK3081215T3 DK16159734.9T DK16159734T DK3081215T3 DK 3081215 T3 DK3081215 T3 DK 3081215T3 DK 16159734 T DK16159734 T DK 16159734T DK 3081215 T3 DK3081215 T3 DK 3081215T3
- Authority
- DK
- Denmark
- Prior art keywords
- alanine
- beta
- procedures
- compositions
- long
- Prior art date
Links
- UCMIRNVEIXFBKS-UHFFFAOYSA-N beta-alanine Chemical compound NCCC(O)=O UCMIRNVEIXFBKS-UHFFFAOYSA-N 0.000 title 2
- 229940000635 beta-alanine Drugs 0.000 title 1
- 230000007774 longterm Effects 0.000 title 1
- 238000000034 method Methods 0.000 title 1
- 239000000203 mixture Substances 0.000 title 1
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/20—Pills, tablets, discs, rods
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/185—Acids; Anhydrides, halides or salts thereof, e.g. sulfur acids, imidic, hydrazonic or hydroximic acids
- A61K31/19—Carboxylic acids, e.g. valproic acid
- A61K31/195—Carboxylic acids, e.g. valproic acid having an amino group
- A61K31/197—Carboxylic acids, e.g. valproic acid having an amino group the amino and the carboxyl groups being attached to the same acyclic carbon chain, e.g. gamma-aminobutyric acid [GABA], beta-alanine, epsilon-aminocaproic acid or pantothenic acid
-
- A—HUMAN NECESSITIES
- A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
- A23L—FOODS, FOODSTUFFS, OR NON-ALCOHOLIC BEVERAGES, NOT COVERED BY SUBCLASSES A21D OR A23B-A23J; THEIR PREPARATION OR TREATMENT, e.g. COOKING, MODIFICATION OF NUTRITIVE QUALITIES, PHYSICAL TREATMENT; PRESERVATION OF FOODS OR FOODSTUFFS, IN GENERAL
- A23L33/00—Modifying nutritive qualities of foods; Dietetic products; Preparation or treatment thereof
- A23L33/10—Modifying nutritive qualities of foods; Dietetic products; Preparation or treatment thereof using additives
- A23L33/17—Amino acids, peptides or proteins
- A23L33/175—Amino acids
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
- A61K31/435—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom
- A61K31/44—Non condensed pyridines; Hydrogenated derivatives thereof
- A61K31/4427—Non condensed pyridines; Hydrogenated derivatives thereof containing further heterocyclic ring systems
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
- A61K31/435—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom
- A61K31/44—Non condensed pyridines; Hydrogenated derivatives thereof
- A61K31/4427—Non condensed pyridines; Hydrogenated derivatives thereof containing further heterocyclic ring systems
- A61K31/444—Non condensed pyridines; Hydrogenated derivatives thereof containing further heterocyclic ring systems containing a six-membered ring with nitrogen as a ring heteroatom, e.g. amrinone
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
- A61K31/435—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom
- A61K31/44—Non condensed pyridines; Hydrogenated derivatives thereof
- A61K31/445—Non condensed piperidines, e.g. piperocaine
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/0087—Galenical forms not covered by A61K9/02 - A61K9/7023
- A61K9/0095—Drinks; Beverages; Syrups; Compositions for reconstitution thereof, e.g. powders or tablets to be dispersed in a glass of water; Veterinary drenches
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/06—Ointments; Bases therefor; Other semi-solid forms, e.g. creams, sticks, gels
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/48—Preparations in capsules, e.g. of gelatin, of chocolate
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/48—Preparations in capsules, e.g. of gelatin, of chocolate
- A61K9/4841—Filling excipients; Inactive ingredients
- A61K9/4858—Organic compounds
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/48—Preparations in capsules, e.g. of gelatin, of chocolate
- A61K9/50—Microcapsules having a gas, liquid or semi-solid filling; Solid microparticles or pellets surrounded by a distinct coating layer, e.g. coated microspheres, coated drug crystals
- A61K9/5005—Wall or coating material
- A61K9/5015—Organic compounds, e.g. fats, sugars
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P21/00—Drugs for disorders of the muscular or neuromuscular system
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P3/00—Drugs for disorders of the metabolism
- A61P3/02—Nutrients, e.g. vitamins, minerals
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P3/00—Drugs for disorders of the metabolism
- A61P3/12—Drugs for disorders of the metabolism for electrolyte homeostasis
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
-
- A—HUMAN NECESSITIES
- A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
- A23V—INDEXING SCHEME RELATING TO FOODS, FOODSTUFFS OR NON-ALCOHOLIC BEVERAGES AND LACTIC OR PROPIONIC ACID BACTERIA USED IN FOODSTUFFS OR FOOD PREPARATION
- A23V2002/00—Food compositions, function of food ingredients or processes for food or foodstuffs
Landscapes
- Health & Medical Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- Chemical & Material Sciences (AREA)
- General Health & Medical Sciences (AREA)
- Veterinary Medicine (AREA)
- Medicinal Chemistry (AREA)
- Public Health (AREA)
- Pharmacology & Pharmacy (AREA)
- Animal Behavior & Ethology (AREA)
- Epidemiology (AREA)
- Engineering & Computer Science (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Chemical Kinetics & Catalysis (AREA)
- General Chemical & Material Sciences (AREA)
- Organic Chemistry (AREA)
- Nutrition Science (AREA)
- Polymers & Plastics (AREA)
- Food Science & Technology (AREA)
- Mycology (AREA)
- Proteomics, Peptides & Aminoacids (AREA)
- Obesity (AREA)
- Hematology (AREA)
- Diabetes (AREA)
- Physical Education & Sports Medicine (AREA)
- Orthopedic Medicine & Surgery (AREA)
- Neurology (AREA)
- Medicinal Preparation (AREA)
- Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Coloring Foods And Improving Nutritive Qualities (AREA)
Applications Claiming Priority (2)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
US68398505P | 2005-05-23 | 2005-05-23 | |
EP06848675.2A EP1883406B1 (en) | 2005-05-23 | 2006-05-23 | Compositions and methods for the sustained release of beta-alanine |
Publications (1)
Publication Number | Publication Date |
---|---|
DK3081215T3 true DK3081215T3 (da) | 2020-04-27 |
Family
ID=38189110
Family Applications (2)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
DK16159734.9T DK3081215T3 (da) | 2005-05-23 | 2006-05-23 | Sammensætninger og fremgangsmåder til langvarig frigørelse af beta-alanin |
DK06848675.2T DK1883406T3 (da) | 2005-05-23 | 2006-05-23 | Sammensætninger og fremgangsmåder til langvarig frigivelse af beta-alanin |
Family Applications After (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
DK06848675.2T DK1883406T3 (da) | 2005-05-23 | 2006-05-23 | Sammensætninger og fremgangsmåder til langvarig frigivelse af beta-alanin |
Country Status (8)
Country | Link |
---|---|
US (8) | US8329207B2 (da) |
EP (2) | EP1883406B1 (da) |
JP (2) | JP5336180B2 (da) |
KR (2) | KR101190791B1 (da) |
CN (2) | CN106038473A (da) |
CA (1) | CA2621365C (da) |
DK (2) | DK3081215T3 (da) |
WO (1) | WO2007073398A2 (da) |
Families Citing this family (27)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US5965596A (en) | 1997-08-12 | 1999-10-12 | Harris; Roger | Methods and compositions for increasing the anaerobic working capacity in tissue |
US7504376B2 (en) | 1996-08-12 | 2009-03-17 | Natural Alternatives International | Methods and compositions for increasing the anaerobic working capacity in tissues |
DK3081215T3 (da) | 2005-05-23 | 2020-04-27 | Natural Alternatives Int Inc | Sammensætninger og fremgangsmåder til langvarig frigørelse af beta-alanin |
US7956218B2 (en) * | 2007-12-12 | 2011-06-07 | Northern Innovations And Formulations Corp. | Organic salts of β-alanine |
EP2231588A4 (en) * | 2007-12-12 | 2011-02-09 | Northern Innovations And Formulations Corp | ORGANIC SALTS OF -ALANINE |
JP5519945B2 (ja) * | 2009-03-10 | 2014-06-11 | 株式会社ファンケル | 抗不安剤 |
WO2011019348A1 (en) * | 2009-08-12 | 2011-02-17 | Kneller Bruce W | CREATINE β-ALANINATE: A NOVEL SALT FOR INCREASING ATHLETIC PERFORMANCE |
US9414615B2 (en) * | 2010-01-18 | 2016-08-16 | PepciCo, Inc. | Gel-based compositions and methods of making same |
TW201201713A (en) * | 2010-04-05 | 2012-01-16 | Abbott Lab | Shelf stable nutritional liquids comprising beta alanine |
WO2013056048A2 (en) * | 2011-10-13 | 2013-04-18 | Abbott Laboratories | Nutritional products comprising beta-alanine |
AU2013207095B2 (en) * | 2012-01-03 | 2016-09-22 | Nestec S.A. | Compositions and methods for the stability of reactive amino acids in a food matrix |
US8496979B1 (en) * | 2012-02-02 | 2013-07-30 | Reliv International, Inc. | Caffeine-free dietary supplements for increasing energy and methods of administering the same |
EP2666365A1 (en) * | 2012-05-22 | 2013-11-27 | Taminco | Treatment of poultry, pigs or fish for reducing the feed conversion ratio. |
ITMI20121586A1 (it) * | 2012-09-24 | 2014-03-25 | N G C Medical Spa | L-carnosina per il trattamento delle miopatia congenita mitocondriale e della sindrome della fatica muscolare cronica |
CN103005435B (zh) * | 2012-12-13 | 2014-01-29 | 北京康比特体育科技股份有限公司 | 一种抗疲劳、提高速度耐力的组合物及含其制剂 |
EP2948139B1 (en) * | 2013-01-28 | 2019-06-12 | Lopez, Hector, L. | Methods of improving tolerability, pharmacodynamics, and efficacy of b-alanine and use therefor |
US20150057354A1 (en) * | 2013-08-20 | 2015-02-26 | Natural Alternatives International, Inc. | Method of maintaining or improving tactical performance and cognitive function through dietary supplementation |
WO2016138454A1 (en) * | 2015-02-27 | 2016-09-01 | Natural Alternatives International, Inc. | Methods of improving physiological responses related to post-traumatic stress disorder through dietary supplementation |
WO2017053171A1 (en) * | 2015-09-25 | 2017-03-30 | Natural Alternatives International, Inc. | Methods of improving physiological conditions related to pregnancy and development of offspring through dietary supplementation |
CN105663081B (zh) | 2015-12-30 | 2019-08-02 | 大连医诺生物股份有限公司 | 微囊化β-丙氨酸 |
US10529418B2 (en) * | 2016-02-19 | 2020-01-07 | Hewlett Packard Enterprise Development Lp | Linear transformation accelerators |
WO2018226987A1 (en) * | 2017-06-07 | 2018-12-13 | The Regents Of The University Of California | Compositions for treating fungal and bacterial biofilms and methods of using the same |
EP3991790A4 (en) * | 2019-06-28 | 2023-10-25 | Yuki Gosei Kogyo Co., Ltd. | MITOCHONDRIAL FUNCTION ACTIVATOR |
JP6749665B1 (ja) * | 2019-07-18 | 2020-09-02 | 株式会社東洋新薬 | 経口組成物 |
US11850217B2 (en) | 2020-05-20 | 2023-12-26 | Advanced Food Concepts, Inc. | Athletic performance enhancement composition using menthol |
CN111956780A (zh) * | 2020-08-28 | 2020-11-20 | 黑龙江现代物联网科技有限公司 | 一种用鹅肌肽制成降低人体尿酸的饮用水及其制备方法 |
CN113812635B (zh) * | 2021-09-22 | 2023-12-19 | 大连医诺生物股份有限公司 | 微囊化β-丙氨酸、其制备方法及应用 |
Family Cites Families (52)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US3966988A (en) * | 1971-07-28 | 1976-06-29 | International Flavors & Fragrances Inc. | Flavoring compositions and processes utilizing dithiazine compounds |
USRE30370E (en) * | 1971-11-04 | 1980-08-12 | International Flavors & Fragrances Inc. | Flavoring foodstuffs with a thioester |
DE2519656A1 (de) * | 1974-05-13 | 1975-11-27 | Sandoz Ag | Neue peptide und verfahren zu ihrer herstellung |
US3934036A (en) * | 1975-01-23 | 1976-01-20 | Kyorin Seiyaku Kabushiki Kaisha | N-benzenesulfonyl-β-alanine hydrazide useful as an immunosuppressive agent |
JPS54159393A (en) | 1978-06-08 | 1979-12-17 | Ajinomoto Co Inc | Polyamino acid-coated activated carbon |
US4328245A (en) | 1981-02-13 | 1982-05-04 | Syntex (U.S.A.) Inc. | Carbonate diester solutions of PGE-type compounds |
US4410545A (en) | 1981-02-13 | 1983-10-18 | Syntex (U.S.A.) Inc. | Carbonate diester solutions of PGE-type compounds |
US4409239A (en) * | 1982-01-21 | 1983-10-11 | Syntex (U.S.A.) Inc. | Propylene glycol diester solutions of PGE-type compounds |
US4389393A (en) * | 1982-03-26 | 1983-06-21 | Forest Laboratories, Inc. | Sustained release therapeutic compositions based on high molecular weight hydroxypropylmethylcellulose |
US4522811A (en) * | 1982-07-08 | 1985-06-11 | Syntex (U.S.A.) Inc. | Serial injection of muramyldipeptides and liposomes enhances the anti-infective activity of muramyldipeptides |
JPS6016934A (ja) | 1983-07-06 | 1985-01-28 | Kaneshiro Nagai | 抗腫瘍剤 |
IT1176983B (it) * | 1984-10-16 | 1987-08-26 | Zambon Spa | Dipeptidi ad attivita' farmacologica |
JPS61204120A (ja) | 1985-03-07 | 1986-09-10 | Kaneshiro Nagai | 免疫調節剤 |
US4713244A (en) * | 1985-08-16 | 1987-12-15 | Bausch & Lomb Incorporated | Sustained-release formulation containing an amino acid polymer with a lower alkyl (C1 -C4) polar solvent |
DE3613758A1 (de) * | 1986-04-23 | 1987-10-29 | Consortium Elektrochem Ind | Cysteinreiche, (gamma)-glutaminsaeure- und (beta)-alanin-einheiten aufweisende peptide, verfahren zu deren herstellung und ihre verwendung |
FR2609893B1 (fr) | 1987-01-26 | 1990-03-30 | Rougereau Andre | Composition a base d'acides amines et de vitamines utilisable en therapeutique cancerologique |
JPS6442425A (en) | 1987-08-11 | 1989-02-14 | Nippon Univ | Remedy for cachexia |
WO1990006102A1 (en) | 1988-09-28 | 1990-06-14 | Peptide Technology Limited | Compound and method for the retardation of collagen cross-linking |
JPH0395125A (ja) | 1989-05-23 | 1991-04-19 | Otsuka Pharmaceut Co Ltd | カルシウム代謝改善剤 |
IT1240336B (it) | 1990-03-21 | 1993-12-07 | Setra | Composizioni farmaceutiche,dietetiche o veterinarie ad attivita' eumetabolica |
JP2873493B2 (ja) | 1990-08-09 | 1999-03-24 | 理化学研究所 | 血糖調節剤 |
JP2873497B2 (ja) | 1990-09-03 | 1999-03-24 | 理化学研究所 | 脂質代謝調節剤 |
US5190775A (en) * | 1991-05-29 | 1993-03-02 | Balchem Corporation | Encapsulated bioactive substances |
WO1993004690A1 (en) | 1991-09-09 | 1993-03-18 | Peptide Technology Limited | Method for the treatment of the complications and pathology of diabetes |
JPH0624976A (ja) | 1992-07-10 | 1994-02-01 | Rikagaku Kenkyusho | 輸液用組成物 |
GB9215746D0 (en) | 1992-07-24 | 1992-09-09 | Hultman Eric | A method of increasing creatine supply depot |
TW333456B (en) * | 1992-12-07 | 1998-06-11 | Takeda Pharm Ind Co Ltd | A pharmaceutical composition of sustained-release preparation the invention relates to a pharmaceutical composition of sustained-release preparation which comprises a physiologically active peptide. |
JP3213666B2 (ja) * | 1994-02-28 | 2001-10-02 | 治彦 末岡 | クレアチン飲料の製造方法 |
ES2188644T3 (es) * | 1994-09-30 | 2003-07-01 | Oreal | Utilizacion de una sustancia agonista de un receptor asociado con un canal de cloro en el tratamiento de las arrugas. |
JP3595373B2 (ja) | 1995-02-20 | 2004-12-02 | 治彦 末岡 | クレアチン飲料 |
IT1275434B (it) * | 1995-05-19 | 1997-08-07 | Farmila Farma Milano | Composizioni farmaceutiche e/o dietetiche ad attivita' antiossidante |
EP0877617A1 (en) * | 1996-01-24 | 1998-11-18 | Aliatros Medical A.S. | Composition for treating cancer containing a ribose compound, beta-alanine, ascorbic acid and nicotinic acid |
US6274161B1 (en) * | 1996-05-31 | 2001-08-14 | The Howard Foundation | Compositions containing creatine in suspension |
GB9611356D0 (en) | 1996-05-31 | 1996-08-07 | Howard Alan N | Improvements in or relating to compositions containing Creatine, and other ergogenic compounds |
US6264970B1 (en) | 1996-06-26 | 2001-07-24 | Takeda Chemical Industries, Ltd. | Sustained-release preparation |
US7504376B2 (en) | 1996-08-12 | 2009-03-17 | Natural Alternatives International | Methods and compositions for increasing the anaerobic working capacity in tissues |
ATE208144T1 (de) * | 1996-08-12 | 2001-11-15 | Harris Roger C | Verfahren und zusammensetzungen zur steigerung der anaerobe leistungsfähigkeit in geweben |
US5965596A (en) * | 1997-08-12 | 1999-10-12 | Harris; Roger | Methods and compositions for increasing the anaerobic working capacity in tissue |
DE69838750T2 (de) * | 1997-05-16 | 2008-10-30 | Amgen Inc., Thousand Oaks | Zeitverzögerte gelzusammensetzungen mit verlängerter wirkstoffverabreichung |
US6019999A (en) * | 1997-12-03 | 2000-02-01 | Miller; David F. | Process for making liposomal ion-exchange whey protein and products thereof |
CN1173742C (zh) | 1997-12-26 | 2004-11-03 | 山之内制药株式会社 | 缓释药物组合物 |
US20010041187A1 (en) * | 1998-10-20 | 2001-11-15 | Carl W Hastings | Performance-enhancing dietary supplement |
GB9924650D0 (en) * | 1999-10-19 | 1999-12-22 | Marathade Ltd | Energy bar |
WO2003024427A1 (en) * | 1999-12-20 | 2003-03-27 | Temple University Of The Commonwealth System Of Higher Education | Tableted oral extended release dosage form |
WO2001078683A2 (en) | 2000-04-19 | 2001-10-25 | Genentech, Inc. | Sustained release formulations comprising growth hormone |
JP2002051730A (ja) | 2000-08-08 | 2002-02-19 | Nippon Meat Packers Inc | スポーツ用食品 |
US6855727B2 (en) | 2000-12-04 | 2005-02-15 | Yaizu Suisankagaku Industry Co., Ltd. | Muscular fatigue-controlling composition and method for providing muscular fatigue-controlling effect |
CA2434156A1 (en) | 2000-12-29 | 2002-07-25 | Bausch & Lomb Incorporated | Sustained release drug delivery devices |
DK1363509T3 (da) | 2001-03-02 | 2007-02-12 | Howard Foundation | Sammensætninger indeholdende creatin og creatinin |
AU2003234146A1 (en) * | 2002-04-22 | 2003-11-03 | Experimental And Applied Sciences, Inc. | Food supplements containing 4-hydroxyisoleucine and creatine |
US6835397B2 (en) * | 2002-12-23 | 2004-12-28 | Balchem Corporation | Controlled release encapsulated bioactive substances |
DK3081215T3 (da) | 2005-05-23 | 2020-04-27 | Natural Alternatives Int Inc | Sammensætninger og fremgangsmåder til langvarig frigørelse af beta-alanin |
-
2006
- 2006-05-23 DK DK16159734.9T patent/DK3081215T3/da active
- 2006-05-23 KR KR1020077030038A patent/KR101190791B1/ko active IP Right Grant
- 2006-05-23 CN CN201610347735.0A patent/CN106038473A/zh active Pending
- 2006-05-23 CN CN200680026773.0A patent/CN101309688B/zh active Active
- 2006-05-23 DK DK06848675.2T patent/DK1883406T3/da active
- 2006-05-23 KR KR1020127017805A patent/KR101275660B1/ko active IP Right Grant
- 2006-05-23 JP JP2008513675A patent/JP5336180B2/ja active Active
- 2006-05-23 EP EP06848675.2A patent/EP1883406B1/en active Active
- 2006-05-23 WO PCT/US2006/020104 patent/WO2007073398A2/en active Application Filing
- 2006-05-23 US US12/064,005 patent/US8329207B2/en active Active
- 2006-05-23 CA CA2621365A patent/CA2621365C/en active Active
- 2006-05-23 EP EP16159734.9A patent/EP3081215B9/en active Active
-
2012
- 2012-10-05 US US13/646,184 patent/US8394402B2/en active Active
-
2013
- 2013-01-31 US US13/755,954 patent/US8496958B2/en active Active
- 2013-06-18 JP JP2013127444A patent/JP2013224310A/ja active Pending
- 2013-06-27 US US13/929,251 patent/US8980307B2/en active Active
-
2015
- 2015-02-19 US US14/626,739 patent/US9636315B2/en active Active
-
2016
- 2016-08-18 US US15/240,460 patent/US9907769B2/en active Active
-
2018
- 2018-02-02 US US15/886,964 patent/US10828274B2/en active Active
-
2020
- 2020-10-06 US US17/064,506 patent/US12036196B2/en active Active
Also Published As
Similar Documents
Publication | Publication Date | Title |
---|---|---|
DK3081215T3 (da) | Sammensætninger og fremgangsmåder til langvarig frigørelse af beta-alanin | |
DK1858864T3 (da) | Stabiliserede sammensætninger af flygtige alkyleringsmidler og fremgangsmåder til anvendelse deraf | |
DK1937824T3 (da) | Sammensætninger af tRNA og anvendelser deraf | |
DK2001611T3 (da) | Fremgangsmåde og sammensætning til oprensning af jord | |
DK1969007T3 (da) | Sammensætninger og fremgangsmåder til fremstilling af en sammensætning | |
DK2135603T3 (da) | Sammensætninger og fremgangsmåder til øgning af insulinsensitivitet | |
DK3308788T3 (da) | Sammensætninger og fremgangsmåder til modulering af smn2-splejsning | |
DK1856374T3 (da) | Sammensætning og fremgangsmåde til fremstilling af et støttemiddel | |
DK2087002T3 (da) | Sammensætninger og fremgangsmåder til binding af sphingosin-1-phosphat | |
DK1879566T3 (da) | Sammensætninger og fremgangsmåder til inhibering af mavesyresekretion | |
DK2137537T3 (da) | Sammensætninger og anvendelser til behandling af multipel sklerose | |
DK2570467T3 (da) | Sammensætninger af tetrafluorpropen og carbonhydrider | |
DK2220116T3 (da) | Sammensætninger og fremgangsmåder til terapien og diagnosticeringen af influenza | |
DK1948695T3 (da) | Immunogene sammensætninger og fremgangsmåder til andvendelse | |
DK2155188T3 (da) | Fremgangsmåder og sammensætninger til behandling af tilbagevendende kræft | |
DK1888033T3 (da) | Fremgangsmåde og sammensætning til behandling af inflammatoriske sygdomme | |
DK2102398T3 (da) | Fremgangsmåde til fremstilling af en ankelsok og ankelsok opnået derved | |
DK1831154T3 (da) | Fremstilling af pregabalin og relaterede forbindelser | |
DK2460820T3 (da) | PCV2-immunogene sammensætninger og fremgangsmåder til fremstilling af sådanne sammensætninger | |
DK3263589T5 (da) | Peptidsekvenser og sammensætninger | |
DK2029746T3 (da) | Sammensætninger og fremgangsmåder til siRNA-hæmning af angiogenese | |
DK2048941T3 (da) | Fremgangsmåde til opdræt af rovmider | |
DK2066339T3 (da) | Sammensætninger og fremgangsmåder til forstærkning af immunreaktioner | |
DK2069467T3 (da) | Adskillende sammensætninger og fremgangsmåder til anvendelse | |
DK1891208T3 (da) | Hidtil ukendte cellulære sammensætninger og fremgangsmåder til fremstilling deraf |